Literature DB >> 25544819

Association of aortic stiffness to brain natriuretic peptide in children before and after device closure of patent ductus arteriosus.

Ragab A Mahfouz1, Ahmad Alzaiat1, Marwa Gad1.   

Abstract

OBJECTIVES: We evaluated the influence of device closure for patent ductus arteriosus (PDA) on the aortic stiffness index (ASI) and brain natriuretic peptide (BNP) and their association with cardiac function. PATIENTS AND METHODS: ASI and echocardiography assessment before and after treatment (16 ± 9 months) in 48 children with PDA (mean age 10 ± 4.5) and 52 control children (mean age 9.7 ± 4.6). BNP level was measured pre-closure for all children, and was measured six months after closure only for children with PDA.
RESULTS: ASI was higher in PDA patients than in controls (P < 0.001). ASI correlated with age (P < 0.05), LVEF% (P < 0.01), E/E' (<0.03), pulmonary artery pressure (P < 0.001), and BNP (P < 0.001). ASI and BNP significantly decreased after closure (P < 0.001). ASI and BNP were independent predictors for post-closure systolic dysfunction (P < 0.001and <0.005, respectively). Receiver operating curve (ROC) analysis showed that ASI ⩾ 13.5, BNP level ⩾75 pg/ml and basal mean pulmonary artery pressure (PAP) ⩾ 23 were powerful predictors for post-closure systolic function.
CONCLUSION: ASI is significantly associated with BNP and basal PAP in children with PDA. After device closure, aortic distensibility improved significantly and was associated with significant improvement in both systolic and diastolic functions. ASI can be used for monitoring the course of patients with PDA, and may give opportunities for early intervention.

Entities:  

Keywords:  Aortic stiffness; Device closure; Patent ductus arteriosus

Year:  2014        PMID: 25544819      PMCID: PMC4274303          DOI: 10.1016/j.jsha.2014.06.001

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  23 in total

1.  Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.

Authors:  Daniel Holmgren; Andreas Westerlind; Per-Arne Lundberg; Håkan Wåhlander
Journal:  Clin Physiol Funct Imaging       Date:  2005-09       Impact factor: 2.273

2.  Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.

Authors:  K Bando; M W Turrentine; T G Sharp; Y Sekine; T X Aufiero; K Sun; E Sekine; J W Brown
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

3.  Aortic and pulmonary artery stiffness and cardiac function in children at risk for obesity.

Authors:  Ragab A Mahfouz; Ashraf Dewedar; Amr Abdelmoneim; Ekhlas M Hossien
Journal:  Echocardiography       Date:  2012-06-14       Impact factor: 1.724

4.  Children with congenital heart disease: probability of natural survival.

Authors:  M Samánek
Journal:  Pediatr Cardiol       Date:  1992-07       Impact factor: 1.655

5.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

6.  Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.

Authors:  T G Yandle; A M Richards; A Gilbert; S Fisher; S Holmes; E A Espiner
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

7.  The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function: a prospective study using two- and three-dimensional echocardiography and measurements of serum natriuretic peptides.

Authors:  Anneli Eerola; Eero Jokinen; Talvikki Boldt; Jaana Pihkala
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

8.  Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function.

Authors:  R O Bonow; E Lakatos; B J Maron; S E Epstein
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

9.  Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy.

Authors:  A Westerlind; H Wåhlander; G Lindstedt; P A Lundberg; D Holmgren
Journal:  Acta Paediatr       Date:  2004-03       Impact factor: 2.299

10.  Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study.

Authors:  Andreas Jekell; Karin Malmqvist; N Håkan Wallén; David Mörtsell; Thomas Kahan
Journal:  J Cardiovasc Pharmacol       Date:  2013-12       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.